Ligand Pharmaceuticals Inc. Share Price
NASDAQ: LGNDHealthcare
Live Ligand Pharmaceuticals Inc. Share Price Chart
O H L
Ligand Pharmaceuticals Inc. Performance Overview
Days Range
▼
$280.96Low
$284.39High
Markets Today
| Previous Close | $284.70 |
|---|---|
| Open | $280.96 |
| Volume | 248,808 |
| Day's Range | $280.96 - $284.39 |
| 52W Range | $163.45 - $326.63 |
| Market Cap | $5.49 B |
Historical Performance
| 1M Returns | -1.00 |
|---|---|
| 3M Returns | +3.57 |
| 6M Returns | +35.88 |
| 1Y Returns | +67.64 |
| 5Y Returns | +96.71 |
| 10Y Returns | +146.28 |
Ligand Pharmaceuticals Inc. Fundamentals
| Market Cap | $5.49 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 29.27 |
| PEG Ratio | N/A |
| Revenue | $268.09 M |
| ROE TTM | 0.13 |
| EPS TTM | $9.40 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 5.67 |
| EBITDA | $80.97 M |
| Profit Margin | 46.42 |
| Market Cap | $5.49 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 29.27 |
| PEG Ratio | N/A |
| Revenue | $268.09 M |
| ROE TTM | 0.13 |
| EPS TTM | $9.40 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 5.67 |
| EBITDA | $80.97 M |
| Profit Margin | 46.42 |
Ligand Pharmaceuticals Inc. Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $45.33 M | $47.63 M | $115.46 M | $59.67 M | $51.72 M | $63.69 M |
| Gross Profit + | $32.23 M | $36.46 M | $111.66 M | $56.67 M | $40.35 M | $52.38 M |
| Operating Income | -$36.66 M | $9.72 M | $54.10 M | $13.84 M | $17.37 M | $8.59 M |
| EBITDA | -$27.89 M | $18.24 M | $62.37 M | $28.25 M | $25.58 M | $16.81 M |
| Interest Expense | -$867.00 K | -$1.15 M | -$910.00 K | -$1.78 M | -$1.75 M | -$1.75 M |
| Depreciation | $8.77 M | $8.52 M | $8.27 M | $14.41 M | $8.22 M | $8.21 M |
| Income Before Tax | -$50.18 M | $11.22 M | $141.14 M | $56.78 M | -$24.26 M | $64.30 M |
| Income Tax Expense | -$7.73 M | $6.38 M | $23.86 M | $12.00 M | -$10.91 M | $15.80 M |
| Net Income + | -$42.45 M | $4.85 M | $117.27 M | $44.78 M | -$13.35 M | $48.51 M |
| Net Profit Margin | -93.64% | 10.18% | 101.57% | 75.06% | -25.8% | 76.16% |
Ligand Pharmaceuticals Inc. Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $20.00 K | $20.00 K | $20.00 K | $20.00 K | $20.00 K | $20.00 K |
| Reserve & Surplus | $454.97 M | $469.87 M | $587.54 M | $616.54 M | $600.13 M | $587.73 M |
| Non-Current Liabilities | $51.22 M | $55.34 M | $496.06 M | $505.98 M | $494.12 M | $1.17 B |
| Current Liabilities | $33.17 M | $29.04 M | $30.54 M | $37.45 M | $40.67 M | $46.74 M |
| Total Liabilities | $109.90 M | $120.08 M | $526.60 M | $543.42 M | $534.78 M | $1.22 B |
| Fixed Assets | $262.01 M | $253.76 M | $237.00 M | $225.44 M | $217.34 M | $209.24 M |
| Current Assets | $309.32 M | $352.94 M | $753.92 M | $832.27 M | $865.41 M | $1.46 B |
| Total Assets | $905.43 M | $948.60 M | $1.48 B | $1.56 B | $1.53 B | $2.19 B |
Ligand Pharmaceuticals Inc. Cash Flow
Quarterly
| Dec 2025 | Dec 2025 | Mar 2026 | Mar 2026 | Jun 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | $44.78 M | $44.78 M | -$13.35 M | -$13.35 M | $48.51 M | $48.51 M |
| Operating Cash Flow | $45.91 M | $45.91 M | $48.69 M | $48.69 M | $24.02 M | $24.02 M |
| Investing Cash Flow | -$18.10 M | -$18.10 M | -$94.35 M | -$94.35 M | $321.12 M | $321.12 M |
| Financing Cash Flow | $8.33 M | $8.33 M | -$14.13 M | -$14.13 M | $546.43 M | $546.43 M |
| Change in Cash | $35.55 M | $35.55 M | -$59.83 M | -$59.83 M | $891.61 M | $891.61 M |
Ligand Pharmaceuticals Inc. Return Calculator
The Ligand Pharmaceuticals Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$19,294
Invested Amount$10,000
Est. Returns$9,294
About Ligand Pharmaceuticals Inc.
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
Popular Stocks
FAQs
What is the share price of Ligand Pharmaceuticals Inc. today?
Ligand Pharmaceuticals Inc. (LGND) share price as of September 18, 2026 is $279.24. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Ligand Pharmaceuticals Inc.?
Yes, Indian Investors can invest in the Ligand Pharmaceuticals Inc. (LGND) Share by opening an international trading account with Angel One.
How can I purchase Ligand Pharmaceuticals Inc. shares in India?
Purchasing Ligand Pharmaceuticals Inc. (LGND) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Ligand Pharmaceuticals Inc. (LGND) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Ligand Pharmaceuticals Inc.?
Yes, you can purchase fractional shares of Ligand Pharmaceuticals Inc. (LGND) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Ligand Pharmaceuticals Inc.?
The market capitalization of Ligand Pharmaceuticals Inc. on September 18, 2026, is $5.49 B.
In which sector Ligand Pharmaceuticals Inc. belongs?
Ligand Pharmaceuticals Inc. operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Ligand Pharmaceuticals Inc. stocks?
In order to invest in Ligand Pharmaceuticals Inc. (LGND) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
